The DOI matches its Crossref record; 43 of the 47 references it cites were found in a registry or an index.
Microsatellite Instability and p53 Mutations Are Associated With Abnormal Expression of the MSH2 Gene in Adult Acute Leukemia
Abstract
Microsatellite instability (MSI) and p53 mutations have been reported to occur in a significant proportion of patients with therapy-related acute myeloid leukemia (AML). MSH2 is one of the genes involved in DNA mismatch repair to maintain fidelity of genomic replication, and defects of MSH2 are directly involved in MSI in hereditary nonpolyposis colorectal tumors and other human tumors. We have examined the expression of MSH2 protein by Western blotting in 43 adult leukemia samples, including 42 AML and 1 acute lymphoblastic leukemia (ALL) using the antibody MSH2 (Ab-1) (Calbiochem, La Jolla, CA). Abnormal expression of MSH2 protein was found in 14 of 43 (32.6%) cases; a control antibody to actin was always positive. Of the 14 patients that had abnormal expression of MSH2, 2 had therapy-related acute leukemia and 9 were elderly patients (>60 years of age). Expression of MSH2 mRNA was further examined by reverse transcriptase-polymerase chain reaction (RT-PCR). Deletion of MSH2 mRNA was found in 1 of 14 cases with deficient MSH2 protein expression. This group of patients was also screened for loss of heterozygosity (LOH) at the MSH2 locus using a panel 4 microsatellite markers (D2S367, D2S288, D2S391, and D2S2294). LOH was found in 5 of 11 cases examined. There was no evidence of LOH in 14 patients with normal MSH2 expression who were examined using the same markers. Functional evidence for defective DNA mismatch repair in leukemic cells lacking MSH2 as manifest by MSI was found in 7 of 11 cases studied. Mutations of the p53 gene in these 43 samples were also investigated by direct sequencing of full-length p53 cDNA. Mutations of p53 were found in 6 of 43 cases, including 5 of the 14 (35.7%) cases that did not express MSH2 protein. In contrast, mutation of p53 was only found in 1 of 29 (3.4%) cases with normal MSH2 protein expression (χ2 = 5.720, P < .02). These results suggest that abnormalities of DNA mismatch repair due to defective MSH2 expression could play a key role in leukemogenesis, in particular in AML arising in elderly patients or secondary to previous chemotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several lines of evidence support a role of impaired DNA mismatch repair (MMR) in leukemogenesis23–25.”
From Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia (2015) · cites this paper as [24]
Citations
Cites
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,884
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Ionov, Y., Peinado, M. A., Malkhosyan, S. R., Shibata, D. K., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,691
Grimwade, D. J., Walker, H., Oliver, F., Wheatley, K., Harrison, C. J., Harrison, G., Rees, J., Hann, I. M., Stevens, R., Burnett, A. K., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,649
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
MISMATCH REPAIR IN REPLICATION FIDELITY, GENETIC RECOMBINATION, AND CANCER BIOLOGY
Modrich, P. L., & Lahue, R. S. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.000533 · Cited by 1,510
Leith, C. P., Kopecky, K. J., Godwin, J. E., McConnell, T. S., Slovak, M. L., Chen, I.-M., Head, D. R., Appelbaum, F. R., & Willman, C. L. (1997) · Blood · doi:10.1182/blood.v89.9.3323 · Cited by 859
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
Liu, B., Nicolaides, N. C., Markowitz, S. D., Willson, J. K. V., Parsons, R. E., Jen, J., Papadopolous, N., Peltomäki, P., de la Chapelle, A., Hamilton, S. R., et al. (1995) · Nature Genetics · doi:10.1038/ng0195-48 · Cited by 801
p53: oncogene or anti-oncogene?Preprint
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 796
de Wind, N., Dekker, M., Berns, A. J. M., Radman, M., & Riele, H. T. (1995) · Cell · doi:10.1016/0092-8674(95)90319-4 · Cited by 780
A Southwest Oncology Group study
Jenkins, T. R., Tangen, C. M., Macdonald, J. S., Weiss, G. R., Chapman, R. M., & Hantel, A. (1993) · Cited by 773
Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P., & Fenaux, P. (1994) · Blood · doi:10.1182/blood.v84.9.3148.3148 · Cited by 592
Thibodeau, S. N., French, A. J., Roche, P. C., Cunningham, J. M., Tester, D. J., Lindor, N. M., Möslein, G., Baker, S. M., Liskay, R. M., Burgart, L. J., et al. (1996) · PubMed · Cited by 466
Instability of short tandem repeats (microsatellites) in human cancers
Wooster, R., Cleton-Jansen, A. M., Collins, N., Mangion, J., Cornelis, R. S., Cooper, C. S., Gusterson, B. A., Ponder, B. A. J., von Deimling, A., Wiestler, O. D., et al. (1994) · Nature Genetics · doi:10.1038/ng0294-152 · Cited by 404
MSH2 deficient mice are viable and susceptible to lymphoid tumours
Reitmair, A. H., Schmits, R., Ewel, A., Bapat, B. V., Redston, M. S., Mitri, A., Waterhouse, P. D., Mittrücker, H., Wakeham, A. C., Liu, B., et al. (1995) · Nature Genetics · doi:10.1038/ng0995-64 · Cited by 376
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.
Liu, B., Parsons, R. E., Hamilton, S. R., Petersen, G. M., Lynch, H. T., Watson, P., Markowitz, S. D., Willson, J. K. V., Green, J., & de la Chapelle, A. (1994) · PubMed · Cited by 360
Umar, A., Boyer, J. C., Thomas, D. C., Nguyen, D. H. V., Risinger, J. I., Boyd, J. A., Ionov, Y., Perucho, M., & Kunkel, T. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36630-9 · Cited by 331
Vogelstein, B. (1990) · Nature · doi:10.1038/348681a0 · Cited by 324
Boyer, J. C., Umar, A., Risinger, J. I., Lipford, J. R., Kane, M., Yin, S., Barrett, J. C., Kolodner, R. D., & Kunkel, T. A. (1995) · PubMed · Cited by 307
Structure of the Human MSH2 Locus and Analysis of Two Muir-Torre Kindreds for msh2 Mutations
Kolodner, R. D., Hall, N. R., Lipford, J. R., Kane, M., Rao, M. R. S., Morrison, P., Wirth, L. J., Finan, P. J., Burn, J., Chapman, P. D., et al. (1994) · Genomics · doi:10.1006/geno.1994.1661 · Cited by 276
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
Bubb, V., Curtis, L. J., Cunningham, C., Dunlop, M. G., Carothers, A. D., Rg, M., White, S., Bird, C. C., & Wyllie, A. H. (1996) · PubMed · Cited by 246
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype
Ben‐Yehuda, D., Krichevsky, S., Caspi, O., Rund, D. G., Polliack, A., Abeliovich, D., Zelig, O., Bogomolski-Yahalom, V., Paltiel, O., Or, R., et al. (1996) · Blood · doi:10.1182/blood.v88.11.4296.bloodjournal88114296 · Cited by 192
DNA mismatch repair and cancer
Chung, D. C., & Rustgi, A. K. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90660-6 · Cited by 179
Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood
Wada, M., Bartram, C., Nakamura, H., Hachiya, M., Chen, D., Borenstein, J. E., Cw, M., Ludwig, L., Hansen-Hagge, T., & Ludwig, W. (1993) · Blood · doi:10.1182/blood.v82.10.3163.3163 · Cited by 179
Brimmell, M., Mendiola, R., Mangion, J., & Packham, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201704 · Cited by 168
Binding of Mismatched Microsatellite DNA Sequences by the Human MSH2 Protein
Fishel, R. A., Ewel, A., Lee, S., Lescoe, M. K., & Griffith, J. D. (1994) · Science · doi:10.1126/science.7973733 · Cited by 164
Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas
Børresen‐Dale, A., Lothe, R. A., Meling, G., Lystad, S., Morrison, P., Lipford, J. R., Kane, M., Rognum, T. O., & Kolodner, R. D. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.11.2065 · Cited by 163
Mutation of the p53 gene in human acute myelogenous leukemia
Slingerland, J., Minden, M., & Benchimol, S. (1991) · Blood · doi:10.1182/blood.v77.7.1500.bloodjournal7771500 · Cited by 130
Genetic instability in human ovarian cancer cell lines.
Orth, K., Hung, J. Y., Gazdar, A. F., Bowcock, A. M., Mathis, J. M., & Sambrook, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9495 · Cited by 128
Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia
Diccianni, M. B., Yu, A. L.-T., Hsiao, M., Mukherjee, S., Shao, L.-E., & Yu, A. L.-T. (1994) · Blood · doi:10.1182/blood.v84.9.3105.3105 · Cited by 123
Mutations of the P53 gene in acute myeloid leukaemia
Fenaux, P., Preudhomme, C., Quiquandon, I., Jonveaux, P., Laı̈, J. L., Vanrumbeke, M., Loucheux‐Lefebvre, M. H., Bauters, F., Berger, R., & Kerckaert, J. P. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb08897.x · Cited by 117
Lazar, V., Grandjouan, S., Bognel, C., Couturier, D., Rougier, P. R., Bellet, D. H., & Paillerets, B. B. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2257 · Cited by 93
Purified human MSH2 protein binds to DNA containing mismatched nucleotides.
Fishel, R. A., Ewel, A., & Lescoe, M. K. (1994) · PubMed · Cited by 89
Hsiao, M., Yu, A. L.-T., Yeargin, J., Ku, D., & Haas, M. (1994) · Blood · doi:10.1182/blood.v83.10.2922.2922 · Cited by 82
Lowsky, R., DeCoteau, J. F., Reitmair, A. H., Ichinohasama, R., Dong, W.-F., Xu, Y., Mak, T. W., Kadin, M. E., & Minden, M. D. (1997) · Blood · doi:10.1182/blood.v89.7.2276 · Cited by 78
Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells.
Marra, G., Chang, C., Laghi, L., Chauhan, D. P., Young, D. J., & Boland, C. R. (1996) · PubMed · Cited by 71
Percesepe, A., Kristo, P., Aaltonen, L. A., de Leòn, M. P., de la Chapelle, A., & Peltomäki, P. (1998) · Oncogene · doi:10.1038/sj.onc.1201944 · Cited by 71
Cell cycle regulation of the human DNA mismatch repair genes hMSH2, hMLH1, and hPMS2.
Meyers, M., Theodosiou, M., Acharya, S., Odegaard, E., Wilson, T., Lewis, J. E., Davis, T. W., Patten, C. W.-V., Fishel, R. A., & Boothman, D. A. (1997) · PubMed · Cited by 61
P53 gene mutations in acute myelogenous leukaemia
Hu, G., Zhang, W., & Deisseroth, A. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb02979.x · Cited by 56
Microsatellite instability during the progression of acute myelocytic leukaemia
Tasaka, T., Lee, S., Spira, S., Takeuchi, S., Nagai, M., Takahara, J., & Koeffler, H. P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1672985.x · Cited by 43
Rarity of microsatellite alterations in acute myeloid leukaemia
Sill, H., Goldman, J. M., & Cross, N. C. P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.347 · Cited by 36
Zhu, Y., Foroni, L., McQuaker, I. G., Papaioannou, M., Haynes, A. P., & Russell, H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690183 · Cited by 36
Self-citation
Cited by
Sorted by citations
p53: traffic cop at the crossroads of DNA repair and recombination
Sengupta, S., & Harris, C. C. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1546 · Cited by 544
Mechanisms of therapy-related carcinogenesis
Allan, J. M., & Travis, L. B. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1749 · Cited by 277
Tumor suppressor genes in normal and malignant hematopoiesis
Krug, U. O., Ganser, A., & Koeffler, H. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205322 · Cited by 232
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
Bhatia, R. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.09.013 · Cited by 220
Metadata
- Authors
- Zhu, Y.-M., Das-Gupta, E. P., & Russell, N. H.
- Affiliations
- University of Nottingham (GB)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1999-07-15
- Volume
- 94
- Issue
- 2
- Pages
- 733-740
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2206735890
- Cited by
- 118
- References
- 47
- Citations by year
- 2025: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 8 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- microsatellite instability, TP53 mutation, mismatch repair deficiency, therapy-related acute myeloid leukemia, acute lymphoblastic leukemia, loss of heterozygosity, adult leukemia, germline TP53 mutation
- MeSH terms
- Acute Disease, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, DNA Mutational Analysis, DNA Repair, DNA-Binding Proteins, DNA, Neoplasm, Female, Humans, Karyotyping, Leukemia, Myeloid, Male, Middle Aged, Proto-Oncogene Proteins, RNA, Messenger, RNA, Neoplasm, Leukemia-Lymphoma, Adult T-Cell, Gene Expression Regulation, Leukemic, Genes, p53, DNA, Complementary, Microsatellite Repeats, Reverse Transcriptase Polymerase Chain Reaction, MutS Homolog 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review